Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Apr 15;97(8):1827–1836. doi: 10.1172/JCI118612

Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis.

J Wilborn 1, M Bailie 1, M Coffey 1, M Burdick 1, R Strieter 1, M Peters-Golden 1
PMCID: PMC507250  PMID: 8621765

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive disorder characterized by inflammation, fibroblast proliferation, and accumulation of extracellular matrix proteins. Leukotrienes (LTs) are pro-inflammatory and pro-fibrogenic mediators derived from the 5-lipoxygenase (5-LO) pathway of arachidonic acid metabolism. They are thought to play a role in a number of disease processes, but have received relatively little attention in investigations into the pathogenesis of IPF. In this study, we measured the levels of immunoreactive LTs B(4) and C(4) in homogenates of lung tissue obtained from patients with newly diagnosed, untreated IPF, as compared to levels measured in homogenates of uninvolved nonfibrotic lung tissue from patients undergoing resectional surgery for bronchogenic carcinoma. Compared to homogenates on nonfibrotic control lung, homogenates from IPF patients contained 15-fold more LTB(4) and 5-fold more LTC(4). IPF homogenate levels of LTB(4) were significantly correlated with histologic indices of both inflammation (r=0.861) and fibrosis (r=0.926). Activation of 5-LO is known from in vitro studies to be associated with localization of the enzyme at the nuclear membrane. Immunohistochemical staining for 5-LO protein in alveolar macrophages (AMs) demonstrated that such an "activated" localization pattern was significantly more frequent in IPF lung (19.2+/-3.3% of cells) than in control lung (9.3+/-0.9%); this localization pattern was rarely seen (3.2%) in sections from a truly normal transplant donor lung. Consistent with these data, AMs obtained from IPF patients by bronchoalveolar lavage, purified by adherence, and cultured in the absence of a stimulus for 16 h elaborated significantly greater amounts of LTB(4) and LTC(4) than did control AMs obtained from normal volunteers. These data indicate that the 5-LO pathway is constitutively activated in the lungs of patients with IPF, and the AM represents at least one cellular source of LT overproduction in this disorder. We speculate that LTs participate in the pathogenesis of IPF, and their overproduction in this disorder may be amenable to specific pharmacotherapy.

Full Text

The Full Text of this article is available as a PDF (373.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balter M. S., Toews G. B., Peters-Golden M. Different patterns of arachidonate metabolism in autologous human blood monocytes and alveolar macrophages. J Immunol. 1989 Jan 15;142(2):602–608. [PubMed] [Google Scholar]
  2. Balter M. S., Toews G. B., Peters-Golden M. Multiple defects in arachidonate metabolism in alveolar macrophages from young asymptomatic smokers. J Lab Clin Med. 1989 Dec;114(6):662–673. [PubMed] [Google Scholar]
  3. Baud L., Perez J., Denis M., Ardaillou R. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol. 1987 Feb 15;138(4):1190–1195. [PubMed] [Google Scholar]
  4. Bernard G. R., Korley V., Chee P., Swindell B., Ford-Hutchinson A. W., Tagari P. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1991 Aug;144(2):263–267. doi: 10.1164/ajrccm/144.2.263. [DOI] [PubMed] [Google Scholar]
  5. Bigby T. D., Holtzman M. J. Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects. J Immunol. 1987 Mar 1;138(5):1546–1550. [PubMed] [Google Scholar]
  6. Bitterman P. B., Wewers M. D., Rennard S. I., Adelberg S., Crystal R. G. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest. 1986 Mar;77(3):700–708. doi: 10.1172/JCI112364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  8. Brock T. G., McNish R. W., Peters-Golden M. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J Biol Chem. 1995 Sep 15;270(37):21652–21658. doi: 10.1074/jbc.270.37.21652. [DOI] [PubMed] [Google Scholar]
  9. Brock T. G., Paine R., 3rd, Peters-Golden M. Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J Biol Chem. 1994 Sep 2;269(35):22059–22066. [PubMed] [Google Scholar]
  10. Cantin A. M., North S. L., Fells G. A., Hubbard R. C., Crystal R. G. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest. 1987 Jun;79(6):1665–1673. doi: 10.1172/JCI113005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Capriotti A. M., Furth E. E., Arrasmith M. E., Laposata M. Arachidonate released upon agonist stimulation preferentially originates from arachidonate most recently incorporated into nuclear membrane phospholipids. J Biol Chem. 1988 Jul 15;263(20):10029–10034. [PubMed] [Google Scholar]
  12. Carré P. C., Mortenson R. L., King T. E., Jr, Noble P. W., Sable C. L., Riches D. W. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest. 1991 Dec;88(6):1802–1810. doi: 10.1172/JCI115501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chen X. S., Naumann T. A., Kurre U., Jenkins N. A., Copeland N. G., Funk C. D. cDNA cloning, expression, mutagenesis, intracellular localization, and gene chromosomal assignment of mouse 5-lipoxygenase. J Biol Chem. 1995 Jul 28;270(30):17993–17999. doi: 10.1074/jbc.270.30.17993. [DOI] [PubMed] [Google Scholar]
  14. Cherniack R. M., Colby T. V., Flint A., Thurlbeck W. M., Waldron J., Ackerson L., King T. E., Jr Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991 Oct;144(4):892–900. doi: 10.1164/ajrccm/144.4.892. [DOI] [PubMed] [Google Scholar]
  15. Cloud M. L., Enas G. C., Kemp J., Platts-Mills T., Altman L. C., Townley R., Tinkelman D., King T., Jr, Middleton E., Sheffer A. L. A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis. 1989 Nov;140(5):1336–1339. doi: 10.1164/ajrccm/140.5.1336. [DOI] [PubMed] [Google Scholar]
  16. Cohen P., Noveral J. P., Bhala A., Nunn S. E., Herrick D. J., Grunstein M. M. Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am J Physiol. 1995 Aug;269(2 Pt 1):L151–L157. doi: 10.1152/ajplung.1995.269.2.L151. [DOI] [PubMed] [Google Scholar]
  17. Drazen J. M., O'Brien J., Sparrow D., Weiss S. T., Martins M. A., Israel E., Fanta C. H. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis. 1992 Jul;146(1):104–108. doi: 10.1164/ajrccm/146.1.104. [DOI] [PubMed] [Google Scholar]
  18. Dreisin R. B., Schwarz M. I., Theofilopoulos A. N., Stanford R. E. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med. 1978 Feb 16;298(7):353–357. doi: 10.1056/NEJM197802162980701. [DOI] [PubMed] [Google Scholar]
  19. Dubois C. M., Bissonnette E., Rola-Pleszczynski M. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene B4. Am Rev Respir Dis. 1989 May;139(5):1257–1264. doi: 10.1164/ajrccm/139.5.1257. [DOI] [PubMed] [Google Scholar]
  20. Fine A., Goldstein R. H. The effect of PGE2 on the activation of quiescent lung fibroblasts. Prostaglandins. 1987 Jun;33(6):903–913. doi: 10.1016/0090-6980(87)90117-1. [DOI] [PubMed] [Google Scholar]
  21. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980 Jul 17;286(5770):264–265. doi: 10.1038/286264a0. [DOI] [PubMed] [Google Scholar]
  22. Ford-Hutchinson A. W., Gresser M., Young R. N. 5-Lipoxygenase. Annu Rev Biochem. 1994;63:383–417. doi: 10.1146/annurev.bi.63.070194.002123. [DOI] [PubMed] [Google Scholar]
  23. Garcia J. G., Griffith D. E., Cohen A. B., Callahan K. S. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4. Am Rev Respir Dis. 1989 Jun;139(6):1494–1501. doi: 10.1164/ajrccm/139.6.1494. [DOI] [PubMed] [Google Scholar]
  24. Henderson W. R., Jr Eicosanoids and lung inflammation. Am Rev Respir Dis. 1987 May;135(5):1176–1185. doi: 10.1164/arrd.1987.135.5.1176. [DOI] [PubMed] [Google Scholar]
  25. Israel E., Rubin P., Kemp J. P., Grossman J., Pierson W., Siegel S. C., Tinkelman D., Murray J. J., Busse W., Segal A. T. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med. 1993 Dec 1;119(11):1059–1066. doi: 10.7326/0003-4819-119-11-199312010-00001. [DOI] [PubMed] [Google Scholar]
  26. Johnson H. M., Torres B. A. Leukotrienes: positive signals for regulation of gamma-interferon production. J Immunol. 1984 Jan;132(1):413–416. [PubMed] [Google Scholar]
  27. Jones R. N. The diagnosis of asbestosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):477–478. doi: 10.1164/ajrccm/144.3_Pt_1.477. [DOI] [PubMed] [Google Scholar]
  28. Khalil N., O'Connor R. N., Unruh H. W., Warren P. W., Flanders K. C., Kemp A., Bereznay O. H., Greenberg A. H. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991 Aug;5(2):155–162. doi: 10.1165/ajrcmb/5.2.155. [DOI] [PubMed] [Google Scholar]
  29. Lewis R. A., Austen K. F., Soberman R. J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990 Sep 6;323(10):645–655. doi: 10.1056/NEJM199009063231006. [DOI] [PubMed] [Google Scholar]
  30. Lynch J. P., 3rd, Standiford T. J., Rolfe M. W., Kunkel S. L., Strieter R. M. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis. 1992 Jun;145(6):1433–1439. doi: 10.1164/ajrccm/145.6.1433. [DOI] [PubMed] [Google Scholar]
  31. Martin T. R., Raugi G., Merritt T. L., Henderson W. R., Jr Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J Clin Invest. 1987 Oct;80(4):1114–1124. doi: 10.1172/JCI113168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Martinet Y., Rom W. N., Grotendorst G. R., Martin G. R., Crystal R. G. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med. 1987 Jul 23;317(4):202–209. doi: 10.1056/NEJM198707233170404. [DOI] [PubMed] [Google Scholar]
  33. Mensing H., Czarnetzki B. M. Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol. 1984 Jan;82(1):9–12. doi: 10.1111/1523-1747.ep12258678. [DOI] [PubMed] [Google Scholar]
  34. Miller D. K., Gillard J. W., Vickers P. J., Sadowski S., Léveillé C., Mancini J. A., Charleson P., Dixon R. A., Ford-Hutchinson A. W., Fortin R. Identification and isolation of a membrane protein necessary for leukotriene production. Nature. 1990 Jan 18;343(6255):278–281. doi: 10.1038/343278a0. [DOI] [PubMed] [Google Scholar]
  35. Ozaki T., Hayashi H., Tani K., Ogushi F., Yasuoka S., Ogura T. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1992 Jan;145(1):85–91. doi: 10.1164/ajrccm/145.1.85. [DOI] [PubMed] [Google Scholar]
  36. Peters-Golden M., McNish R. W., Hyzy R., Shelly C., Toews G. B. Alterations in the pattern of arachidonate metabolism accompany rat macrophage differentiation in the lung. J Immunol. 1990 Jan 1;144(1):263–270. [PubMed] [Google Scholar]
  37. Peters-Golden M., McNish R. W. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem Biophys Res Commun. 1993 Oct 15;196(1):147–153. doi: 10.1006/bbrc.1993.2227. [DOI] [PubMed] [Google Scholar]
  38. Peters-Golden M., Shelly C. Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion. J Immunol. 1988 Mar 15;140(6):1958–1966. [PubMed] [Google Scholar]
  39. Phan S. H., Kunkel S. L. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production. Am J Pathol. 1986 Aug;124(2):343–352. [PMC free article] [PubMed] [Google Scholar]
  40. Phan S. H., McGarry B. M., Loeffler K. M., Kunkel S. L. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry. 1988 Apr 19;27(8):2846–2853. doi: 10.1021/bi00408a028. [DOI] [PubMed] [Google Scholar]
  41. Phan S. H., McGarry B. M., Loeffler K. M., Kunkel S. L. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites. J Leukoc Biol. 1987 Aug;42(2):106–113. doi: 10.1002/jlb.42.2.106. [DOI] [PubMed] [Google Scholar]
  42. Rankin J. A., Hitchcock M., Merrill W., Bach M. K., Brashler J. R., Askenase P. W. IgE-dependent release of leukotriene C4 from alveolar macrophages. Nature. 1982 May 27;297(5864):329–331. doi: 10.1038/297329a0. [DOI] [PubMed] [Google Scholar]
  43. Rennard S. I., Hunninghake G. W., Bitterman P. B., Crystal R. G. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7147–7151. doi: 10.1073/pnas.78.11.7147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Robbins R. A., Russ W. D., Thomas K. R., Rasmussen J. K., Kay H. D. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity. Am Rev Respir Dis. 1987 Mar;135(3):659–664. doi: 10.1164/arrd.1987.135.3.659. [DOI] [PubMed] [Google Scholar]
  45. Rouzer C. A., Kargman S. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem. 1988 Aug 5;263(22):10980–10988. [PubMed] [Google Scholar]
  46. Schröder J. M. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med. 1989 Sep 1;170(3):847–863. doi: 10.1084/jem.170.3.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stephenson A. H., Lonigro A. J., Hyers T. M., Webster R. O., Fowler A. A. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis. 1988 Sep;138(3):714–719. doi: 10.1164/ajrccm/138.3.714. [DOI] [PubMed] [Google Scholar]
  48. Strieter R. M., Kasahara K., Allen R. M., Standiford T. J., Rolfe M. W., Becker F. S., Chensue S. W., Kunkel S. L. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol. 1992 Aug;141(2):397–407. [PMC free article] [PubMed] [Google Scholar]
  49. Taylor G. W., Taylor I., Black P., Maltby N. H., Turner N., Fuller R. W., Dollery C. T. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet. 1989 Mar 18;1(8638):584–588. doi: 10.1016/s0140-6736(89)91611-5. [DOI] [PubMed] [Google Scholar]
  50. Thivierge M., Rola-Pleszczynski M. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. J Allergy Clin Immunol. 1992 Nov;90(5):796–802. doi: 10.1016/0091-6749(92)90104-a. [DOI] [PubMed] [Google Scholar]
  51. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax. 1980 Aug;35(8):593–599. doi: 10.1136/thx.35.8.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Vincent J. E., Vermeer M. A., Kort W. J., Zijlstra F. J. The formation of thromboxane B2, leukotriene B4 and 12-hydroxyeicosatetraenoic acid by alveolar macrophages after activation during tumor growth in the rat. Biochim Biophys Acta. 1990 Feb 6;1042(2):255–258. doi: 10.1016/0005-2760(90)90017-r. [DOI] [PubMed] [Google Scholar]
  53. Wardlaw A. J., Hay H., Cromwell O., Collins J. V., Kay A. B. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol. 1989 Jul;84(1):19–26. doi: 10.1016/0091-6749(89)90173-5. [DOI] [PubMed] [Google Scholar]
  54. Westcott J. Y., McDonnell T. J., Voelkel N. F. Alveolar transfer and metabolism of eicosanoids in the rat. Am Rev Respir Dis. 1989 Jan;139(1):80–87. doi: 10.1164/ajrccm/139.1.80. [DOI] [PubMed] [Google Scholar]
  55. Wilborn J., Crofford L. J., Burdick M. D., Kunkel S. L., Strieter R. M., Peters-Golden M. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest. 1995 Apr;95(4):1861–1868. doi: 10.1172/JCI117866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wong A., Hwang S. M., Cook M. N., Hogaboom G. K., Crooke S. T. Interactions of 5-lipoxygenase with membranes: studies on the association of soluble enzyme with membranes and alterations in enzyme activity. Biochemistry. 1988 Sep 6;27(18):6763–6769. doi: 10.1021/bi00418a018. [DOI] [PubMed] [Google Scholar]
  57. Woods J. W., Coffey M. J., Brock T. G., Singer I. I., Peters-Golden M. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J Clin Invest. 1995 May;95(5):2035–2046. doi: 10.1172/JCI117889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Woods J. W., Evans J. F., Ethier D., Scott S., Vickers P. J., Hearn L., Heibein J. A., Charleson S., Singer I. I. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med. 1993 Dec 1;178(6):1935–1946. doi: 10.1084/jem.178.6.1935. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES